Pet Drug and Vaccine Market Size, Growth, Trends and Forecast 2030

The Pet Drug and Vaccine Market is expanding as pet ownership increases and owners become more focused on preventive healthcare. According to WiseGuyReports, the global market was valued at USD 13.3 billion in 2025 and is projected to reach USD 25 billion by 2035, representing a CAGR of 6.4% during the forecast period.

The growing humanization of pets is encouraging owners to spend more on veterinary medicines, vaccines, nutraceuticals, and specialized treatments. Dogs and cats account for significant demand because of their widespread ownership and increasing access to veterinary services. Preventive healthcare is becoming particularly important as pet owners seek vaccination programs and products that support long-term wellness.

Technological developments are also influencing the market. Veterinary telemedicine, AI-supported diagnostics, and improved drug formulations are helping veterinarians deliver faster and more personalized care. In addition, increasing pet insurance adoption is making advanced veterinary treatments more accessible in several developed markets.

North America currently holds a leading position, while Asia-Pacific is expected to experience strong growth due to increasing pet ownership, urbanization, changing lifestyles, and rising disposable incomes.

Overall, rising healthcare expenditure for companion animals, pharmaceutical innovation, preventive care awareness, and expanding veterinary infrastructure are expected to support continued growth in the global Pet Drug and Vaccine Market through 2035.

Read More
Lukoon https://lukoon.com